International Biotechnology Trust’s Krystal Biotech KRYS Stock Holding History

International Biotechnology Trust’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$5.34M	Buy	46,092 +147	+0.3%	+$17.9K	1.8%	20
2023 Q2	$5.39M	Sell	45,945 -15,055	-25%	-$1.54M	1.64%	22
2023 Q1	$4.88M	Buy	61,000 +16,000	+36%	+$1.26M	1.36%	26
2022 Q4	$3.56M	Hold	45,000	–	–	1.1%	28
2022 Q3	$3.13M	Buy	45,000 +42,045	+1,423%	+$3.04M	1%	31
2022 Q2	$45K	Sell	2,955 -42,045	-93%	-$2.62M	0.47%	46
2022 Q1	$1.11M	Hold	45,000	–	–	0.25%	53
2021 Q4	$3.15M	Buy	+45,000	New	+$2.62M	0.7%	35

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

International Biotechnology Trust's KRYS Position: Q3 2023 in Review

International Biotechnology Trust increased its Krystal Biotech (KRYS) stake by 0.32% in Q3 2023, buying an estimated $17.9K and bringing the position to 46,092 shares worth $5.34M. The position accounts for 1.8% of the portfolio, ranked #20.

International Biotechnology Trust first reported a position in KRYS in Q4 2021 and has held it in 8 quarters since. The position peaked at $5.39M in Q2 2023. 188 funds tracked by Wall St. Rank hold KRYS as of Q3 2023.

International Biotechnology Trust held 46,092 shares of Krystal Biotech worth $5.34M as of Q3 2023.
International Biotechnology Trust bought 147 Krystal Biotech shares in Q3 2023, an estimated $17.9K.
Krystal Biotech made up 1.8% of International Biotechnology Trust's portfolio in Q3 2023, its #20 holding.
International Biotechnology Trust first reported a position in Krystal Biotech in Q4 2021 and has held it in 8 quarters since.
International Biotechnology Trust's Krystal Biotech position peaked at $5.39M in Q2 2023.
188 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.